bd4 Search Results


94
Shanghai Korain Biotech Co Ltd mouse beta defensin 4 elisa kit
Mouse Beta Defensin 4 Elisa Kit, supplied by Shanghai Korain Biotech Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bd4/pmc11707986-44-1-9?v=Shanghai+Korain+Biotech+Co+Ltd
Average 94 stars, based on 1 article reviews
mouse beta defensin 4 elisa kit - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

90
Biomatik full length pbrm1
Full Length Pbrm1, supplied by Biomatik, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bd4/pm36808431-81-13-25?v=Biomatik
Average 90 stars, based on 1 article reviews
full length pbrm1 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Helmholtz Zentrum fur Infektionsforschung GmbH npd profiles for nitrogen and deuterium-loaded γ-mg( 11 bd 4)
Npd Profiles For Nitrogen And Deuterium Loaded γ Mg( 11 Bd 4), supplied by Helmholtz Zentrum fur Infektionsforschung GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bd4/pmc11087247-23-10-56?v=Helmholtz+Zentrum+fur+Infektionsforschung+GmbH
Average 90 stars, based on 1 article reviews
npd profiles for nitrogen and deuterium-loaded γ-mg( 11 bd 4) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
PharmatrophiX Inc ptx bd4-3
Ptx Bd4 3, supplied by PharmatrophiX Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bd4/pmc07391412-183-12-18?v=PharmatrophiX+Inc
Average 90 stars, based on 1 article reviews
ptx bd4-3 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Becton Dickinson facs-caliburtm bd 4 color flow cytometer
Facs Caliburtm Bd 4 Color Flow Cytometer, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bd4/us09816989-880-5-6?v=Becton+Dickinson
Average 90 stars, based on 1 article reviews
facs-caliburtm bd 4 color flow cytometer - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Becton Dickinson facs-calibur bd 4 color flow cytometer
Facs Calibur Bd 4 Color Flow Cytometer, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bd4/us10365275-1103-5-6?v=Becton+Dickinson
Average 90 stars, based on 1 article reviews
facs-calibur bd 4 color flow cytometer - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Sony il-4 apc (bd4-8) antibody
Il 4 Apc (Bd4 8) Antibody, supplied by Sony, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bd4/pmc09972971-47-37-40?v=Sony
Average 90 stars, based on 1 article reviews
il-4 apc (bd4-8) antibody - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
NanoTemper Technologies pbrm1-bd4 protein
<t>PBRM1</t> incurs frequent missense mutations in the context of cancer. A , proportion of cancer-associated PBRM1 variants by mutation type, as annotated in the COSMIC (Catalog of Somatic Mutations in Cancer) database. B , percentage of cancer-associated missense mutations of PBRM1 by functional domain, as annotated in the COSMIC database. C , cancer-associated missense mutations of <t>PBRM1-BD4</t> per residue across the entire peptide sequence, as annotated in the COSMIC database. Bromodomains (BD; blue ), bromo-adjacent homology (BAH; red ), and high-mobility group (HMG; green ) domains are denoted, with domain boundaries determined from Pfam annotations ± 15 aa residues. D , structure-based sequence alignment of PBRM1 bromodomains, with the position of the four bromodomain ⍺-helices ( blue ) shown above. BD4 and the residues studied herein are highlighted within the sequence alignment. The heat map demonstrates the conservation level per residue across the six PBRM1 bromodomains, where higher conservation is indicated by reds and lower conservation is indicated by blues . E , Rosetta flexible peptide docking of an H3K14ac peptide ( gray ) from PBRM1-BD2 (PDB ID 2KTB ) to PBRM1-BD4 (PDB ID 3TLP ) ; mutated residues are represented as spheres and color-coded by the number of unique missense variants per residue examined in this study. H3K14ac, lysine-14 acetylation on histone H3; PBRM1, polybromo-1.
Pbrm1 Bd4 Protein, supplied by NanoTemper Technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bd4/pmc11002309-224-16-39?v=NanoTemper+Technologies
Average 90 stars, based on 1 article reviews
pbrm1-bd4 protein - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Becton Dickinson bd 4-laser fortessa
<t>PBRM1</t> incurs frequent missense mutations in the context of cancer. A , proportion of cancer-associated PBRM1 variants by mutation type, as annotated in the COSMIC (Catalog of Somatic Mutations in Cancer) database. B , percentage of cancer-associated missense mutations of PBRM1 by functional domain, as annotated in the COSMIC database. C , cancer-associated missense mutations of <t>PBRM1-BD4</t> per residue across the entire peptide sequence, as annotated in the COSMIC database. Bromodomains (BD; blue ), bromo-adjacent homology (BAH; red ), and high-mobility group (HMG; green ) domains are denoted, with domain boundaries determined from Pfam annotations ± 15 aa residues. D , structure-based sequence alignment of PBRM1 bromodomains, with the position of the four bromodomain ⍺-helices ( blue ) shown above. BD4 and the residues studied herein are highlighted within the sequence alignment. The heat map demonstrates the conservation level per residue across the six PBRM1 bromodomains, where higher conservation is indicated by reds and lower conservation is indicated by blues . E , Rosetta flexible peptide docking of an H3K14ac peptide ( gray ) from PBRM1-BD2 (PDB ID 2KTB ) to PBRM1-BD4 (PDB ID 3TLP ) ; mutated residues are represented as spheres and color-coded by the number of unique missense variants per residue examined in this study. H3K14ac, lysine-14 acetylation on histone H3; PBRM1, polybromo-1.
Bd 4 Laser Fortessa, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bd4/pm38700378-353-8-7?v=Becton+Dickinson
Average 90 stars, based on 1 article reviews
bd 4-laser fortessa - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Chemie GmbH chemie, bd.4,1889, s. 457
<t>PBRM1</t> incurs frequent missense mutations in the context of cancer. A , proportion of cancer-associated PBRM1 variants by mutation type, as annotated in the COSMIC (Catalog of Somatic Mutations in Cancer) database. B , percentage of cancer-associated missense mutations of PBRM1 by functional domain, as annotated in the COSMIC database. C , cancer-associated missense mutations of <t>PBRM1-BD4</t> per residue across the entire peptide sequence, as annotated in the COSMIC database. Bromodomains (BD; blue ), bromo-adjacent homology (BAH; red ), and high-mobility group (HMG; green ) domains are denoted, with domain boundaries determined from Pfam annotations ± 15 aa residues. D , structure-based sequence alignment of PBRM1 bromodomains, with the position of the four bromodomain ⍺-helices ( blue ) shown above. BD4 and the residues studied herein are highlighted within the sequence alignment. The heat map demonstrates the conservation level per residue across the six PBRM1 bromodomains, where higher conservation is indicated by reds and lower conservation is indicated by blues . E , Rosetta flexible peptide docking of an H3K14ac peptide ( gray ) from PBRM1-BD2 (PDB ID 2KTB ) to PBRM1-BD4 (PDB ID 3TLP ) ; mutated residues are represented as spheres and color-coded by the number of unique missense variants per residue examined in this study. H3K14ac, lysine-14 acetylation on histone H3; PBRM1, polybromo-1.
Chemie, Bd.4,1889, S. 457, supplied by Chemie GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bd4/10__1515_slash_bchm2__1904__41__3__177-181-2-0?v=Chemie+GmbH
Average 90 stars, based on 1 article reviews
chemie, bd.4,1889, s. 457 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Becton Dickinson bd-4 solution
<t>PBRM1</t> incurs frequent missense mutations in the context of cancer. A , proportion of cancer-associated PBRM1 variants by mutation type, as annotated in the COSMIC (Catalog of Somatic Mutations in Cancer) database. B , percentage of cancer-associated missense mutations of PBRM1 by functional domain, as annotated in the COSMIC database. C , cancer-associated missense mutations of <t>PBRM1-BD4</t> per residue across the entire peptide sequence, as annotated in the COSMIC database. Bromodomains (BD; blue ), bromo-adjacent homology (BAH; red ), and high-mobility group (HMG; green ) domains are denoted, with domain boundaries determined from Pfam annotations ± 15 aa residues. D , structure-based sequence alignment of PBRM1 bromodomains, with the position of the four bromodomain ⍺-helices ( blue ) shown above. BD4 and the residues studied herein are highlighted within the sequence alignment. The heat map demonstrates the conservation level per residue across the six PBRM1 bromodomains, where higher conservation is indicated by reds and lower conservation is indicated by blues . E , Rosetta flexible peptide docking of an H3K14ac peptide ( gray ) from PBRM1-BD2 (PDB ID 2KTB ) to PBRM1-BD4 (PDB ID 3TLP ) ; mutated residues are represented as spheres and color-coded by the number of unique missense variants per residue examined in this study. H3K14ac, lysine-14 acetylation on histone H3; PBRM1, polybromo-1.
Bd 4 Solution, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bd4/pm21706704-85-21-21?v=Becton+Dickinson
Average 90 stars, based on 1 article reviews
bd-4 solution - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Biochemie GmbH handbuch der biochemie, bd. 4
<t>PBRM1</t> incurs frequent missense mutations in the context of cancer. A , proportion of cancer-associated PBRM1 variants by mutation type, as annotated in the COSMIC (Catalog of Somatic Mutations in Cancer) database. B , percentage of cancer-associated missense mutations of PBRM1 by functional domain, as annotated in the COSMIC database. C , cancer-associated missense mutations of <t>PBRM1-BD4</t> per residue across the entire peptide sequence, as annotated in the COSMIC database. Bromodomains (BD; blue ), bromo-adjacent homology (BAH; red ), and high-mobility group (HMG; green ) domains are denoted, with domain boundaries determined from Pfam annotations ± 15 aa residues. D , structure-based sequence alignment of PBRM1 bromodomains, with the position of the four bromodomain ⍺-helices ( blue ) shown above. BD4 and the residues studied herein are highlighted within the sequence alignment. The heat map demonstrates the conservation level per residue across the six PBRM1 bromodomains, where higher conservation is indicated by reds and lower conservation is indicated by blues . E , Rosetta flexible peptide docking of an H3K14ac peptide ( gray ) from PBRM1-BD2 (PDB ID 2KTB ) to PBRM1-BD4 (PDB ID 3TLP ) ; mutated residues are represented as spheres and color-coded by the number of unique missense variants per residue examined in this study. H3K14ac, lysine-14 acetylation on histone H3; PBRM1, polybromo-1.
Handbuch Der Biochemie, Bd. 4, supplied by Biochemie GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bd4/10__1007_slash_bf01751542-56-2-6?v=Biochemie+GmbH
Average 90 stars, based on 1 article reviews
handbuch der biochemie, bd. 4 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


PBRM1 incurs frequent missense mutations in the context of cancer. A , proportion of cancer-associated PBRM1 variants by mutation type, as annotated in the COSMIC (Catalog of Somatic Mutations in Cancer) database. B , percentage of cancer-associated missense mutations of PBRM1 by functional domain, as annotated in the COSMIC database. C , cancer-associated missense mutations of PBRM1-BD4 per residue across the entire peptide sequence, as annotated in the COSMIC database. Bromodomains (BD; blue ), bromo-adjacent homology (BAH; red ), and high-mobility group (HMG; green ) domains are denoted, with domain boundaries determined from Pfam annotations ± 15 aa residues. D , structure-based sequence alignment of PBRM1 bromodomains, with the position of the four bromodomain ⍺-helices ( blue ) shown above. BD4 and the residues studied herein are highlighted within the sequence alignment. The heat map demonstrates the conservation level per residue across the six PBRM1 bromodomains, where higher conservation is indicated by reds and lower conservation is indicated by blues . E , Rosetta flexible peptide docking of an H3K14ac peptide ( gray ) from PBRM1-BD2 (PDB ID 2KTB ) to PBRM1-BD4 (PDB ID 3TLP ) ; mutated residues are represented as spheres and color-coded by the number of unique missense variants per residue examined in this study. H3K14ac, lysine-14 acetylation on histone H3; PBRM1, polybromo-1.

Journal: The Journal of Biological Chemistry

Article Title: Cancer-associated polybromo-1 bromodomain 4 missense variants variably impact bromodomain ligand binding and cell growth suppression

doi: 10.1016/j.jbc.2024.107146

Figure Lengend Snippet: PBRM1 incurs frequent missense mutations in the context of cancer. A , proportion of cancer-associated PBRM1 variants by mutation type, as annotated in the COSMIC (Catalog of Somatic Mutations in Cancer) database. B , percentage of cancer-associated missense mutations of PBRM1 by functional domain, as annotated in the COSMIC database. C , cancer-associated missense mutations of PBRM1-BD4 per residue across the entire peptide sequence, as annotated in the COSMIC database. Bromodomains (BD; blue ), bromo-adjacent homology (BAH; red ), and high-mobility group (HMG; green ) domains are denoted, with domain boundaries determined from Pfam annotations ± 15 aa residues. D , structure-based sequence alignment of PBRM1 bromodomains, with the position of the four bromodomain ⍺-helices ( blue ) shown above. BD4 and the residues studied herein are highlighted within the sequence alignment. The heat map demonstrates the conservation level per residue across the six PBRM1 bromodomains, where higher conservation is indicated by reds and lower conservation is indicated by blues . E , Rosetta flexible peptide docking of an H3K14ac peptide ( gray ) from PBRM1-BD2 (PDB ID 2KTB ) to PBRM1-BD4 (PDB ID 3TLP ) ; mutated residues are represented as spheres and color-coded by the number of unique missense variants per residue examined in this study. H3K14ac, lysine-14 acetylation on histone H3; PBRM1, polybromo-1.

Article Snippet: As PBRM1-BD4 lacks Trp residues, intrinsic Tyr fluorescence at 330 nm was plotted versus temperature, and PBRM1-BD4 protein T m was determined by identifying the maximum of the first derivative of the fluorescence signal with ThermControl software version 2.3.1 (NanoTemper Technologies, https://nanotempertech.com/prometheus/nt48-software ).

Techniques: Mutagenesis, Functional Assay, Residue, Sequencing

Cancer-associated PBRM1-BD4 missense variants primarily exhibit decreased protein stability with intact secondary and tertiary structure integrity. A , PBRM1-BD4 missense variant T m determined by SYPRO Orange thermal shift assay (controls shown in light gray , cancer-associated PBRM1-BD4 missense variants in dark gray ); ΔT m of PBRM1-BD4 variants compared to WT is also demonstrated (negative ΔT m denoted in blue , positive Δ T m in red ), where error bars represent SD; n = 9 for PBRM1-BD4 WT and all missense variants except N601K, where n = 6. B , heat map indicates a change in Gibbs free energy (ΔΔ G ) of PBRM1-BD4 missense variants compared to WT estimated by Rosetta modeling software (more divergent values shown in blue , less divergent in red ). C , correlation of SYPRO Orange thermal shift assay and ΔΔ G datasets, where horizontal error bars represent SD of protein melting temperatures determined by the SYPRO Orange thermal shift assay. D , CD spectrum of PBRM1-BD4 missense variant R540T. E , CD spectrum of PBRM1-BD4 missense variant R576P. F , 1 H-NMR spectra of PBRM1-BD4 WT and cancer-associated PBRM1-BD4 missense variants. The gray highlighted regions correspond to the spectral regions (backbone amide proton ∼6.5–9.5 ppm; saturated alkane methyl proton ∼0–1.25 ppm) used to assess variant tertiary structural integrity ( , ). BD4, fourth bromodomain; CD, circular dichroism; 1 H-NMR, one-dimensional proton NMR spectroscopy; PBRM1, polybromo-1; T m , protein melting temperature.

Journal: The Journal of Biological Chemistry

Article Title: Cancer-associated polybromo-1 bromodomain 4 missense variants variably impact bromodomain ligand binding and cell growth suppression

doi: 10.1016/j.jbc.2024.107146

Figure Lengend Snippet: Cancer-associated PBRM1-BD4 missense variants primarily exhibit decreased protein stability with intact secondary and tertiary structure integrity. A , PBRM1-BD4 missense variant T m determined by SYPRO Orange thermal shift assay (controls shown in light gray , cancer-associated PBRM1-BD4 missense variants in dark gray ); ΔT m of PBRM1-BD4 variants compared to WT is also demonstrated (negative ΔT m denoted in blue , positive Δ T m in red ), where error bars represent SD; n = 9 for PBRM1-BD4 WT and all missense variants except N601K, where n = 6. B , heat map indicates a change in Gibbs free energy (ΔΔ G ) of PBRM1-BD4 missense variants compared to WT estimated by Rosetta modeling software (more divergent values shown in blue , less divergent in red ). C , correlation of SYPRO Orange thermal shift assay and ΔΔ G datasets, where horizontal error bars represent SD of protein melting temperatures determined by the SYPRO Orange thermal shift assay. D , CD spectrum of PBRM1-BD4 missense variant R540T. E , CD spectrum of PBRM1-BD4 missense variant R576P. F , 1 H-NMR spectra of PBRM1-BD4 WT and cancer-associated PBRM1-BD4 missense variants. The gray highlighted regions correspond to the spectral regions (backbone amide proton ∼6.5–9.5 ppm; saturated alkane methyl proton ∼0–1.25 ppm) used to assess variant tertiary structural integrity ( , ). BD4, fourth bromodomain; CD, circular dichroism; 1 H-NMR, one-dimensional proton NMR spectroscopy; PBRM1, polybromo-1; T m , protein melting temperature.

Article Snippet: As PBRM1-BD4 lacks Trp residues, intrinsic Tyr fluorescence at 330 nm was plotted versus temperature, and PBRM1-BD4 protein T m was determined by identifying the maximum of the first derivative of the fluorescence signal with ThermControl software version 2.3.1 (NanoTemper Technologies, https://nanotempertech.com/prometheus/nt48-software ).

Techniques: Variant Assay, Thermal Shift Assay, Software, Circular Dichroism, Proton NMR, Spectroscopy

Cancer-associated PBRM1-BD4 missense variants exhibit variable ligand binding capacity. A , heat map indicates PBRM1-BD4 variant (0.1–10 μM) binding of H3K14ac peptide (50 nM) compared to WT in AlphaScreen assays (n = 3). B , AlphaScreen titrations of PBRM1-BD4 P556S, M586I, and R576L (0.001–2 μM) against a biotinylated histone H3K14ac (50 nM) peptide (n = 3), where error bars represent SEM. C , EMSA of PBRM1-BD4 WT (0–50 μM) binding to 150 nM Widom 601 DNA (representative of n = 2). D , EMSA of PBRM1-BD4 variants (20 μM) binding to 150 nM Widom 601 DNA (representative of n = 2). Alpha, amplified luminescent proximity homogeneous assay; BD4, fourth bromodomain; EMSA, electrophoretic mobility shift assay; H3K14ac, lysine-14 acetylation on histone H3; PBRM1, polybromo-1.

Journal: The Journal of Biological Chemistry

Article Title: Cancer-associated polybromo-1 bromodomain 4 missense variants variably impact bromodomain ligand binding and cell growth suppression

doi: 10.1016/j.jbc.2024.107146

Figure Lengend Snippet: Cancer-associated PBRM1-BD4 missense variants exhibit variable ligand binding capacity. A , heat map indicates PBRM1-BD4 variant (0.1–10 μM) binding of H3K14ac peptide (50 nM) compared to WT in AlphaScreen assays (n = 3). B , AlphaScreen titrations of PBRM1-BD4 P556S, M586I, and R576L (0.001–2 μM) against a biotinylated histone H3K14ac (50 nM) peptide (n = 3), where error bars represent SEM. C , EMSA of PBRM1-BD4 WT (0–50 μM) binding to 150 nM Widom 601 DNA (representative of n = 2). D , EMSA of PBRM1-BD4 variants (20 μM) binding to 150 nM Widom 601 DNA (representative of n = 2). Alpha, amplified luminescent proximity homogeneous assay; BD4, fourth bromodomain; EMSA, electrophoretic mobility shift assay; H3K14ac, lysine-14 acetylation on histone H3; PBRM1, polybromo-1.

Article Snippet: As PBRM1-BD4 lacks Trp residues, intrinsic Tyr fluorescence at 330 nm was plotted versus temperature, and PBRM1-BD4 protein T m was determined by identifying the maximum of the first derivative of the fluorescence signal with ThermControl software version 2.3.1 (NanoTemper Technologies, https://nanotempertech.com/prometheus/nt48-software ).

Techniques: Ligand Binding Assay, Variant Assay, Binding Assay, Amplified Luminescent Proximity Homogenous Assay, Amplification, Electrophoretic Mobility Shift Assay

Structural insights into the functional effects of cancer-associated PBRM1-BD4 missense variants. A , conserved residue Y580 stabilizes the loop-helix fold between the AB loop and the adjacent α B helix. B , frequently mutated residue R576 helps maintain the structural integrity of the α Z helix. C , frequently mutated residues M523 and M586 in the α Z and α B helices contribute to the stability of the PBRM1-BD4 α-helical core. D , conserved residue R540 contributes to the histone Kac binding pocket and adjacent α C helix stability. BD4, fourth bromodomain; PBRM1, polybromo-1.

Journal: The Journal of Biological Chemistry

Article Title: Cancer-associated polybromo-1 bromodomain 4 missense variants variably impact bromodomain ligand binding and cell growth suppression

doi: 10.1016/j.jbc.2024.107146

Figure Lengend Snippet: Structural insights into the functional effects of cancer-associated PBRM1-BD4 missense variants. A , conserved residue Y580 stabilizes the loop-helix fold between the AB loop and the adjacent α B helix. B , frequently mutated residue R576 helps maintain the structural integrity of the α Z helix. C , frequently mutated residues M523 and M586 in the α Z and α B helices contribute to the stability of the PBRM1-BD4 α-helical core. D , conserved residue R540 contributes to the histone Kac binding pocket and adjacent α C helix stability. BD4, fourth bromodomain; PBRM1, polybromo-1.

Article Snippet: As PBRM1-BD4 lacks Trp residues, intrinsic Tyr fluorescence at 330 nm was plotted versus temperature, and PBRM1-BD4 protein T m was determined by identifying the maximum of the first derivative of the fluorescence signal with ThermControl software version 2.3.1 (NanoTemper Technologies, https://nanotempertech.com/prometheus/nt48-software ).

Techniques: Functional Assay, Residue, Binding Assay

Cancer-associated PBRM1-BD4 missense variants exhibit impaired stability and acetylated histone binding. A , immunoblot demonstrates equivalent expression of full-length PBRM1-BD4 missense variants in a Caki-2 tetracycline-inducible system. B , coimmunoprecipitation with BRG1 and V5-tagged PBRM1. C , immunoblots of V5-tagged PBRM1-BD4 WT and PBRM1-BD4 missense variants and beta-actin from Caki-2 cells treated with 100 μg/ml cycloheximide for 0, 2, 6, 10, or 24 h. D , immunoblot densitometry quantitation of PBRM1-BD4 WT and PBRM1-BD4 missense variants at 2 h of cycloheximide treatment. Significance was calculated using an unpaired Student’s t test, where ∗ p < 0.05, and error bars represent the SEM. E , correlation of PBRM1-BD4 WT and PBRM1-BD4 missense variant protein stability as assessed by the cellular cycloheximide chase assay at 2 h and the biophysical SYPRO Orange thermal shift assay, where horizontal error bars represent SD of immunoblot densitometry quantitation at 2 h of cycloheximide treatment and vertical error bars represent SD of protein T m values determined by the SYPRO Orange thermal shift assay. F , acetylated histone H3 peptide pulldown (n = 2) by PBRM1 WT and PBRM1-BD4 missense variants as measured by fold enrichment of H3K14,18,23,27ac(1–30) over input. Significance was calculated using an unpaired Student’s t test where ∗ p < 0.05 and error bars represent SEM. BD4, fourth bromodomain; BRG1, brahma-related gene 1; PBRM1, polybromo-1; T m , protein melting temperature.

Journal: The Journal of Biological Chemistry

Article Title: Cancer-associated polybromo-1 bromodomain 4 missense variants variably impact bromodomain ligand binding and cell growth suppression

doi: 10.1016/j.jbc.2024.107146

Figure Lengend Snippet: Cancer-associated PBRM1-BD4 missense variants exhibit impaired stability and acetylated histone binding. A , immunoblot demonstrates equivalent expression of full-length PBRM1-BD4 missense variants in a Caki-2 tetracycline-inducible system. B , coimmunoprecipitation with BRG1 and V5-tagged PBRM1. C , immunoblots of V5-tagged PBRM1-BD4 WT and PBRM1-BD4 missense variants and beta-actin from Caki-2 cells treated with 100 μg/ml cycloheximide for 0, 2, 6, 10, or 24 h. D , immunoblot densitometry quantitation of PBRM1-BD4 WT and PBRM1-BD4 missense variants at 2 h of cycloheximide treatment. Significance was calculated using an unpaired Student’s t test, where ∗ p < 0.05, and error bars represent the SEM. E , correlation of PBRM1-BD4 WT and PBRM1-BD4 missense variant protein stability as assessed by the cellular cycloheximide chase assay at 2 h and the biophysical SYPRO Orange thermal shift assay, where horizontal error bars represent SD of immunoblot densitometry quantitation at 2 h of cycloheximide treatment and vertical error bars represent SD of protein T m values determined by the SYPRO Orange thermal shift assay. F , acetylated histone H3 peptide pulldown (n = 2) by PBRM1 WT and PBRM1-BD4 missense variants as measured by fold enrichment of H3K14,18,23,27ac(1–30) over input. Significance was calculated using an unpaired Student’s t test where ∗ p < 0.05 and error bars represent SEM. BD4, fourth bromodomain; BRG1, brahma-related gene 1; PBRM1, polybromo-1; T m , protein melting temperature.

Article Snippet: As PBRM1-BD4 lacks Trp residues, intrinsic Tyr fluorescence at 330 nm was plotted versus temperature, and PBRM1-BD4 protein T m was determined by identifying the maximum of the first derivative of the fluorescence signal with ThermControl software version 2.3.1 (NanoTemper Technologies, https://nanotempertech.com/prometheus/nt48-software ).

Techniques: Binding Assay, Western Blot, Expressing, Quantitation Assay, Variant Assay, Thermal Shift Assay

Cancer-associated PBRM1-BD4 missense variants exhibit impaired cancer cell growth suppression and PBRM1 target gene regulation. A , workflow of the FACS cell proliferation competition assay. B , Caki-2 PBRM1 WT and PBRM1-BD4 missense variant cell growth over 22 days. Significant differences between cell lines were calculated using a two-way ANOVA (mixed model) with Tukey post hoc analysis where ∗ p < 0.05 and ∗∗ p < 0.01, and colored wedges around trendlines represent SD (n = 2 for vector, n = 4 for WT, n = 3 for missense variants). C , RT-qPCR (n = 3) of select PBRM1 target and nontarget genes. Significance was calculated using an unpaired Student’s t test where ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001 and error bars represent the SEM. BD4, fourth bromodomain; FACS, fluorescence-activated cell sorting; PBRM1, polybromo-1; RT-qPCR, quantitative real-time PCR.

Journal: The Journal of Biological Chemistry

Article Title: Cancer-associated polybromo-1 bromodomain 4 missense variants variably impact bromodomain ligand binding and cell growth suppression

doi: 10.1016/j.jbc.2024.107146

Figure Lengend Snippet: Cancer-associated PBRM1-BD4 missense variants exhibit impaired cancer cell growth suppression and PBRM1 target gene regulation. A , workflow of the FACS cell proliferation competition assay. B , Caki-2 PBRM1 WT and PBRM1-BD4 missense variant cell growth over 22 days. Significant differences between cell lines were calculated using a two-way ANOVA (mixed model) with Tukey post hoc analysis where ∗ p < 0.05 and ∗∗ p < 0.01, and colored wedges around trendlines represent SD (n = 2 for vector, n = 4 for WT, n = 3 for missense variants). C , RT-qPCR (n = 3) of select PBRM1 target and nontarget genes. Significance was calculated using an unpaired Student’s t test where ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001 and error bars represent the SEM. BD4, fourth bromodomain; FACS, fluorescence-activated cell sorting; PBRM1, polybromo-1; RT-qPCR, quantitative real-time PCR.

Article Snippet: As PBRM1-BD4 lacks Trp residues, intrinsic Tyr fluorescence at 330 nm was plotted versus temperature, and PBRM1-BD4 protein T m was determined by identifying the maximum of the first derivative of the fluorescence signal with ThermControl software version 2.3.1 (NanoTemper Technologies, https://nanotempertech.com/prometheus/nt48-software ).

Techniques: Competitive Binding Assay, Variant Assay, Plasmid Preparation, Quantitative RT-PCR, Fluorescence, FACS, Real-time Polymerase Chain Reaction